These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32479678)

  • 21. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
    Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
    Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors in 105 Japanese cases of mycosis fungoides and Sézary syndrome: clusterin expression as a novel prognostic factor.
    Tobisawa S; Honma M; Ishida-Yamamoto A; Saijo Y; Iizuka H
    J Dermatol Sci; 2013 Sep; 71(3):160-6. PubMed ID: 23702390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folliculotropism Does Not Affect Overall Survival in Mycosis Fungoides: Results from a Single-Center Cohort and Meta-Analysis.
    Giberson M; Mourad A; Gniadecki R
    Dermatology; 2017; 233(4):320-325. PubMed ID: 29169156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA-IIA Mycosis Fungoides.
    Querfeld C; Scarisbrick JJ; Assaf C; Guenova E; Bagot M; Ortiz-Romero PL; Quaglino P; Bonizzoni E; Hodak E
    Dermatology; 2022; 238(2):347-357. PubMed ID: 34091453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients.
    van Doorn R; Van Haselen CW; van Voorst Vader PC; Geerts ML; Heule F; de Rie M; Steijlen PM; Dekker SK; van Vloten WA; Willemze R
    Arch Dermatol; 2000 Apr; 136(4):504-10. PubMed ID: 10768649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poikilodermatous mycosis fungoides: a study of its clinicopathological, immunophenotypic, and prognostic features.
    Abbott RA; Sahni D; Robson A; Agar N; Whittaker S; Scarisbrick JJ
    J Am Acad Dermatol; 2011 Aug; 65(2):313-319. PubMed ID: 21529998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group.
    van Santen S; van Doorn R; Neelis KJ; Daniëls LA; Horváth B; Bruijn MS; Sanders CJG; van Rossum MM; de Haas ERM; Veraart JCJM; Bekkenk MW; Vermeer MH; Willemze R
    Br J Dermatol; 2017 Jul; 177(1):223-228. PubMed ID: 28132406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement.
    Doerschner M; Pekar-Lukacs A; Messerli-Odermatt O; Dommann-Scherrer C; Rütti M; Müller AM; Nair G; Kamarachev J; Kerl K; Beer M; Messerli M; Frauenknecht K; Haralambieva E; Hoetzenecker W; French LE; Guenova E
    Br J Dermatol; 2019 Dec; 181(6):1296-1302. PubMed ID: 30565216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcomes of 1,263 patients with mycosis fungoides and Sézary syndrome from 1982 to 2009.
    Talpur R; Singh L; Daulat S; Liu P; Seyfer S; Trynosky T; Wei W; Duvic M
    Clin Cancer Res; 2012 Sep; 18(18):5051-60. PubMed ID: 22850569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic indicators for mycosis fungoides in a Greek population.
    Nikolaou V; Papadavid E; Patsatsi A; Siakantaris M; Economidi A; Marinos L; Koletsa T; Georgiou E; Pappa V; Stratigos A; Antoniou C
    Br J Dermatol; 2017 May; 176(5):1321-1330. PubMed ID: 27552962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycosis fungoides in pediatric patients: Clinical features, diagnostic challenges, and advances in therapeutic management.
    Wu JH; Cohen BA; Sweren RJ
    Pediatr Dermatol; 2020 Jan; 37(1):18-28. PubMed ID: 31630432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced-stage mycosis fungoides and Sézary syndrome: survival and response to treatment.
    Alberti-Violetti S; Talpur R; Schlichte M; Sui D; Duvic M
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e105-12. PubMed ID: 25817937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides.
    Kim YH; Chow S; Varghese A; Hoppe RT
    Arch Dermatol; 1999 Jan; 135(1):26-32. PubMed ID: 9923777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
    Talpur R; Venkatarajan S; Duvic M
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
    Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
    Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment.
    Hoppe RT; Wood GS; Abel EA
    Curr Probl Cancer; 1990; 14(6):293-371. PubMed ID: 2245651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How I treat mycosis fungoides and Sézary syndrome.
    Whittaker S; Hoppe R; Prince HM
    Blood; 2016 Jun; 127(25):3142-53. PubMed ID: 27151889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paediatric mycosis fungoides - characteristics, management and outcomes with particular focus on the folliculotropic variant.
    Reiter O; Amitay-Laish I; Oren-Shabtai M; Feinmesser M; Ben-Amitai D; Hodak E
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):671-679. PubMed ID: 35080278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stage-dependent Increase in Expression of miR-155 and Ki-67 and Number of Tumour-associated Inflammatory Cells in Folliculotropic Mycosis Fungoides.
    Atzmony L; Moyal L; Feinmesser M; Gorovitz B; Hirshberg A; Amitay-Laish I; Prag-Naveh H; Barzilai A; Hodak E
    Acta Derm Venereol; 2020 Aug; 100(15):adv00230. PubMed ID: 32556361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.